Y-Biologics is a biotech company that focuses on the development of innovative immunotherapies using its dual antibody platform. They have established a global competitive human antibody library technology and a next-generation immunotherapy technology, a new dual antibody format. They are developing a number of effective immunotherapies based on these technologies.